Evidence-based Text Messages to Target Diet and Physical Activity

January 16, 2025 updated by: Yvonne Kiera Bartlett, University of Manchester

Developing Evidence-based Text Messages to Target Diet and Physical Activity Behaviour for People with Type 2 Diabetes Mellitus

This research aims to develop a bank of text messages based on behaviour change techniques targeting specific diet and physical activity behaviours in people with type 2 diabetes

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Aim: To develop text messages that help people with type 2 diabetes (T2D) improve their diet and level of physical activity

What is known:

Following diet and physical activity advice helps to reduce the risk of health problems for people with T2D

Just telling people about a healthy diet, or ideal levels of physical activity may not change what someone does day-to-day. Many people need support to change health behaviours

Techniques designed to help people change their behaviour, such as setting goals, can help people act

Text messages can be sent to large numbers of people, for a low cost

For the best chance of success, it is important that the messages are a) acceptable to the people receiving them and b) use techniques to help people to make changes

How the investigators are going to achieve their aim:

When asking someone to follow a healthy diet or do more physical activity, this could refer to changing lots of different behaviours such as eating less sugar or less fat and walking each day. The investigators invited people with type 2 diabetes, doctors, nurses, dietitians, and researchers to take part in a workshop to work out which behaviours are the most important ones for people with type 2 diabetes to do. The investigators have also looked at previous research and found techniques that have helped people with type 2 diabetes change their diet and levels of activity.

The investigators will now follow four steps to develop the messages:

  1. Twelve to fifteen people with type 2 diabetes will take part in online focus groups to provide feedback about the target behaviours and guide the development of the text message system
  2. Ten to twenty researchers will take part in a workshop. They will write messages using the techniques that have worked in previous research to target important behaviours for people with type 2 diabetes. They will then complete a survey to report whether the messages are good examples of the techniques.

2. Sixty people with type 2 diabetes will complete a survey to tell us whether they like and understand the messages and how useful they think they would be.

3. Forty people with type 2 diabetes will receive the messages for up to 3 months and take part in an interview over the phone to help us understand their experiences.

Patient and Public Involvement and Engagement (PPIE) This research has been developed with a PPIE group. Our PPIE co-applicant and PPIE group will be involved in key decisions and review any materials being sent to people with type 2 diabetes.

What the investigators will do with the findings

Explore how these messages can become part of routine National Health Service (NHS) care. The findings will be used together with work our team are doing looking at sending out text messages to help people with type 2 diabetes take their medication.

Findings will also be publicised through databases of people interested in research, diabetes charities, community groups, places of worship and publications.

Study Type

Interventional

Enrollment (Actual)

148

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Manchester, United Kingdom, M139PL
        • University of Manchester

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

  • For the expert workshop -

Inclusion criteria: researchers with expertise in behaviour change, physical activity, diet and/or diabetes

- For focus group

Inclusion criteria

  • Participant is willing and able to give informed consent for participation in the study.
  • Male or female, aged 18 years or above.
  • A diagnosis of type 2 diabetes.
  • Has access to a mobile-phone (shared access is allowed with permission of phone owner)
  • Able to use a mobile phone, if necessary with help, to send or retrieve brief messages (including text-messages or messaging within smartphone applications).

Exclusion criteria

Moved out of England prior to taking part in the study

For the anticipated acceptability survey and experienced acceptability study

Inclusion criteria

  • Participant is willing and able to give informed consent for participation in the study.
  • Aged 18 years or above.
  • A diagnosis of type 2 diabetes.
  • Has access to a mobile-phone (shared access is allowed with permission of phone owner)
  • Able to use a mobile phone, if necessary with help, to send or retrieve brief messages (including text-messages).

Exclusion criteria

  • Within three months of a hospital admission for hyperglycaemia or hypoglycaemia.
  • Pregnant or within three months post-partum by self-report
  • Underweight (For anticipated acceptability this will be by self-report, for experienced acceptability BMI<18.5)
  • Historical or current diagnosis of an eating disorder Prescribed insulin for their diabetes

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Experienced acceptability study
The final study in this research will involve people with type 2 diabetes receiving the text messages
Text messages based on behaviour change techniques

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Experienced Acceptability of the text messages for people with type 2 diabetes
Time Frame: 3.5 months
Assessed through interviews following receiving the text messages
3.5 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Anticipated Acceptability
Time Frame: 60 minutes
Assessed through online survey
60 minutes
Rating of fidelity to intended behaviour change technique
Time Frame: 60 minutes

How well the text messages represent their intended behaviour change technique. For each behaviour change technique, participants will be presented with the title and description of the technique from the Behaviour change Technique (BCT) v1 taxonomy (Michie et al., 2013, doi: 10.1007/s12160-013-9486-6), and then sample messages. For each message participants will be asked "How well does this message reflect the [specific technique] as defined above?". Answers were given on a 10-point scale anchored with 1 (not very well) to 10 (very well).

This scale has been used in our previous work developing text messages (Bartlett et al., 2020, doi: 10.2196/15989)

60 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kiera Bartlett, PhD, University of Manchester

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 14, 2022

Primary Completion (Actual)

November 23, 2023

Study Completion (Actual)

June 30, 2024

Study Registration Dates

First Submitted

November 17, 2022

First Submitted That Met QC Criteria

November 30, 2022

First Posted (Actual)

December 7, 2022

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 16, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Subject to participant consent. Plan to upload the deidentified survey data with codebook Will explore uploading deidentified transcripts if a relevant database is found

IPD Sharing Time Frame

By December 2023

IPD Sharing Access Criteria

Dependent on the database chosen

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Type 2 Diabetes

Clinical Trials on Text messages

Subscribe